Loading
Latest filing published 07 Aug 2026 for Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.), €14k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Karen DeHaan-Fullerton in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). The record holds 3 filings, for trades running from 13 June 2022 to 5 August 2026.
The open-market record is one-sided, with 1 purchase worth €3,193 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise.
On 7 August 2026 came the latest disclosure, an option exercise for €14k in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). The latest purchase dates back some time: it was published 522 days ago, on 20 May 2025. Filings reach the SEDI feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration